Antibodies to Escherichia coli 0157 in patients with haemorrhagic colitis and haemolytic uraemic syndrome

33Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

Twenty four sera from patients with haemolytic uraemic syndrome or haemorrhagic colitis and healthy controls were examined for antibodies to the lipopolysaccharide (LPS) of Escherichia coli 0157. Faecal specimens from these patients were also examined for Vero cytotoxin producing Ecoli (VTEC) by DNA probes, and for faecal Vero cytotoxin. Eight patients with faecal E coli 0157:H7 gave a strong antibody response to 0157 LPS, shown by immunoblotting and an enzyme linked immunosorbent assay. Six symptomatic patients without evidence of faecal VTEC also gave a strong antibody response to 0157 LPS. Sera from the remaining five patients and five healthy controls did not contain antibodies to E coli 0157. The results suggest that the testing of sera from patients with haemorrhagic colitis or haemolytic uraemic syndrome by ELISA or immunoblot would prove valuable in addition to the established procedures for detecting VTEC, using DNA probes and testing for faecal Vero cytotoxin.

Cite

CITATION STYLE

APA

Chart, H., Scotland, S. M., Smith, H. R., & Rowe, B. (1989). Antibodies to Escherichia coli 0157 in patients with haemorrhagic colitis and haemolytic uraemic syndrome. Journal of Clinical Pathology, 42(9), 973–976. https://doi.org/10.1136/jcp.42.9.973

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free